The Brightfield Group recently released its “U.S. Cannabis Market Forecast” on Feb. 16, which presents data of comparisons from cannabis…
Forget ketamine- and MDMA-assisted therapies: A psychedelics manufacturing company is moving forward with cocaine and heroin—with an end goal to…
Following in the footsteps of Colorado and Oregon, Utah is the latest state to consider the benefits in therapy that…
NFL star quarterback Aaron Rodgers will be a featured speaker at a psychedelics conference to be held in Denver this…
Sen. Ron Kouchi introduced Senate Bill 1454 on Jan. 25, which was unanimously passed in the Hawaii Senate Committee on…
Regulators in Australia this week announced that qualified psychiatrists will be able to prescribe “medicines containing the psychedelic substances psilocybin…
The University of California, Davis announced this week that it is launching a new institute that aims to “advance basic…
Virginia Sen. Ghazala Hashmi’s bill, Senate Bill 932, recently passed in the Senate Education and Health Subcommittee on Jan. 25.…
Legislation proposed in Arizona would provide millions of dollars in grant funding to expand research into psilocybin––the primary psychoactive component…
Two bills were filed in Massachusetts to decriminalize psilocybin mushrooms, ayahuasca, mescaline, and ibogaine. The bills would end the prosecution…